Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Infrastructure-based EGNOS/Galileo receiver for personal mobility

IEGLO

The main goal of the proposed project IEGLO is the development of a handheld tracking device for elderly or Alzheimer disease people. At present, in Europe approximately 4.000.000 people are Alzheimer disease-ridden. Especially this people get very often in situations where they are un-oriented. They need mentoring by either their family members or...

Funding Programme
Start Date
End Date
Total Funding
€ 387 327
European Countries Involved

Intelligent Knowledge Platform for Personal Health Monitoring Services

eHealthMonitor

The eHealthMonitor project provides a platform that generates a Personal eHealth Knowledge Space (PeKS) as an aggregation of all knowledge sources (e.g., EHR and PHR) relevant for the provision of individualized personal eHealth services. This is realised by integrating service-oriented architecture, knowledge engineering, multiagent systems, and...

Funding Programme
Start Date
End Date
Total Funding
€ 4 078 283
European Countries Involved

Joint Action on Dementia 2015-2018

Joint Action on Dementia 2015-2018. The Joint Action will focus on two phases on work: approximately 12 months on developing a consensus on the best evidence of effective action in 4 key areas (diagnosis and post-diagnostic support; crisis and care coordination; quality of care in residential care settings; and dementia-friendly communities); and...

Funding Programme
Start Date
End Date
Total Funding
€ 1 498 710

Magnetic Resonance Methods Development and Applications for Life Sciences

EUROCANMRI

This application is to enable mutual transfer of knowledge and experience by enhancing mutual scientific interest, augmenting research projects and exchanging new ideas. We envision that the collaboration will bring joint publications and new discoveries in the area of Magnetic Resonance (MR). The project aims at the improvement of current...

Funding Programme
Start Date
End Date
Total Funding
€ 91 800
European Countries Involved

Prediction, Monitoring and Personalized Recommendations for Prevention and Relief of Dementia and Frailty

COMFORTAGE

COMFORTAGE is a joint effort of medical experts (i.e., neurologists, psychiatrists, neuropsychologists, nurses, memory clinics), social scientists and humanists, technical experts (i.e., data scientists, AI experts, robotic experts) and Digital Innovation Hubs to establish a pan European framework for Community-based, Integrated and People-Centric...

Funding Programme
Start Date
End Date
Total Funding
€ 17 591 490

Promotion of plasticity as a treatment for neurodegenerative conditions

PLASTICISE

Neurodegenerative diseases all cause damage to the circuitry of the nervous system, with loss of connections, axons and neurons. The loss can be gradual, as in Alzheimer’s disease, rapid as in stroke, or intermediate as in the delayed neuronal loss after stroke. Following damage, the nervous system is able partially to compensate through the...

Funding Programme
Start Date
End Date
Total Funding
€ 6 767 728
European Countries Involved

Psychosocial fActors Relevant to BrAin DISorders in Europe

PARADISE

The overall prevalence of brain disorders – both neurological and psychiatric – is very high in Europe. Although it is well known that the burden and costs of these disorders are high, there is evidence that the overall, personal, social and economic costs of brain disorders have been underestimated because of the lack of valid and reliable...

Funding Programme
Start Date
End Date
Total Funding
€ 1 675 934
European Countries Involved

Robotic Assistant for MCI patients at home

RAMCIP

RAMCIP will research and develop a novel domestic service robot, with the aim to proactively and discreetly assist older persons, MCI and AD patients in their every day life. Instead of simply being an obedient servant, the RAMCIP robot will have high-level cognitive functions, driven through advanced human activity and home environment modelling...

Funding Programme
Start Date
End Date
Total Funding
€ 3 981 178
European Countries Involved

Social Interactive Care System  to support the well-being of people living with dementia (Many-Me)

Many-Me

The main objective of Many-Me is to offer patients in different stages of dementia a friendly and enjoyable environment supported by ICT solutions, empowering them to self-manage their condition by engaging and learning from people in a similar situation, make friends and attend support groups, test and adopt routines or techniques that help memory...

Funding Programme
Start Date
End Date
Total Funding
€ 2 400 000
European Countries Involved

Social Health And Reserve in the Dementia patient journey

SHARED

The role of social health in onset, disease course and prognosis of dementia remains underexplored. Social health has been conceptualized as the influence of social resources in finding a balance between capacities and limitations. Moreover, social health affects and is affected by biological processes that underlie the dementia syndrome. This...

Funding Programme
Start Date
End Date
European Countries Involved

SUstainable PROduction of GALanthamine by both in vitro and agricultural crops of highly galanthamine-containing plants

SUPROGAL

Galanthamine is an alkaloid produced exclusively by plants of the family Amaryllidaceae, mainly belonging to the genus Galanthus, Leucojum and Narcissus. Owing to its acetylcholinesterase inhibitory activity, galanthamine is used and marketed for the treatment of the Alzheimer’s disease, among others. Although it is obtained by organic synthesis...

Funding Programme
Start Date
End Date
Total Funding
€ 1 343 680
European Countries Involved

Ultrafast photonics for the detection and recognition of toxic spine-structures of amyloid aggregates linked to neurodegenerative disease

UPRECON

Projections indicate that, by 2050, every person aged 85 years or more will be diagnosed with a cognition-related disease. While there is currently no clear strategy for curing such diseases, there are promising developments in the early diagnosis of disease and the inhibition of worsening symptoms. Building on results obtained during my post...

Funding Programme
Start Date
End Date
Total Funding
€ 134 462
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).